NCT07204366View on ClinicalTrials.gov

Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)

Active, not recruitingOBSERVATIONAL

Enrollment

219

Participants

Timeline

Start Date

May 6, 2022

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions

Myeloproliferative DiseaseCOVID - 19

Trial Locations (1)

27100

Fondazione IRCCS Policlinico San Matteo, Pavia

All Listed Sponsors

lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER